GPR162 and neoplasm: In summary, we report for the first time a double pituitary corticotroph tumor which harbored a G-protein coupled receptor (GPR162) variant in one tumor and a novel ubiquitin specific protease (USP8) variant in the second corticotroph tumor in the setting of a background germline CYP21A2 variant.